ProShare Advisors LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 215 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$415,387
-37.1%
49,747
+0.2%
0.00%
-50.0%
Q2 2023$660,518
+18.3%
49,663
+3.0%
0.00%0.0%
Q1 2023$558,364
+42.9%
48,218
+0.9%
0.00%
+100.0%
Q4 2022$390,849
+53.9%
47,781
+9.1%
0.00%0.0%
Q3 2022$254,000
+23.3%
43,813
-5.8%
0.00%0.0%
Q2 2022$206,000
-64.8%
46,529
-27.7%
0.00%0.0%
Q1 2022$586,000
-63.8%
64,372
-18.5%
0.00%
-66.7%
Q4 2021$1,618,000
-12.2%
79,023
+9.5%
0.00%
-40.0%
Q3 2021$1,843,000
-38.8%
72,147
-16.2%
0.01%
-44.4%
Q2 2021$3,011,000
+19.8%
86,096
+14.1%
0.01%
+12.5%
Q1 2021$2,513,000
+42.3%
75,434
+10.8%
0.01%
+14.3%
Q4 2020$1,766,000
+265.6%
68,067
+39.1%
0.01%
+250.0%
Q3 2020$483,000
+215.7%
48,942
+10.2%
0.00%
+100.0%
Q2 2020$153,000
+70.0%
44,395
+50.9%
0.00%0.0%
Q1 2020$90,000
-66.5%
29,412
-43.9%
0.00%0.0%
Q4 2019$269,000
-9.4%
52,389
-9.1%
0.00%
-50.0%
Q3 2019$297,000
-17.0%
57,620
-2.7%
0.00%0.0%
Q2 2019$358,000
-25.3%
59,204
-10.7%
0.00%
-33.3%
Q1 2019$479,000
-0.2%
66,310
+2.2%
0.00%0.0%
Q4 2018$480,000
+29.0%
64,890
-5.6%
0.00%0.0%
Q3 2018$372,000
+46.5%
68,709
-3.9%
0.00%
+50.0%
Q2 2018$254,000
+64.9%
71,466
-4.9%
0.00%
+100.0%
Q1 2018$154,000
-25.2%
75,182
-3.6%
0.00%0.0%
Q4 2017$206,000
-45.6%
78,013
+8.0%
0.00%
-66.7%
Q3 2017$379,000
+92.4%
72,229
+30.3%
0.00%
+50.0%
Q2 2017$197,000
-35.0%
55,431
-5.6%
0.00%
-33.3%
Q1 2017$303,000
+7.4%
58,694
-20.8%
0.00%0.0%
Q4 2016$282,000
-52.2%
74,107
+12.6%
0.00%
-62.5%
Q3 2016$590,000
+13.0%
65,807
-11.3%
0.01%
+14.3%
Q2 2016$522,000
-8.6%
74,206
+10.5%
0.01%
-12.5%
Q1 2016$571,000
-38.5%
67,149
-5.1%
0.01%
-27.3%
Q4 2015$929,000
+303.9%
70,774
+12.4%
0.01%
+266.7%
Q3 2015$230,000
-40.6%
62,960
-6.3%
0.00%
-40.0%
Q2 2015$387,000
-6.3%
67,222
-4.9%
0.01%0.0%
Q1 2015$413,000
-11.6%
70,673
+18.6%
0.01%0.0%
Q4 2014$467,000
+60.5%
59,608
+0.6%
0.01%
+25.0%
Q3 2014$291,000
-33.6%
59,237
-16.4%
0.00%
-33.3%
Q2 2014$438,000
-17.4%
70,826
-28.5%
0.01%
-14.3%
Q1 2014$530,000
+209.9%
99,098
+203.1%
0.01%
+133.3%
Q4 2013$171,000
-42.0%
32,698
-38.6%
0.00%
-57.1%
Q3 2013$295,000
+210.5%
53,293
+41.1%
0.01%
+250.0%
Q2 2013$95,00037,7700.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q4 2020
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$137,073,04129.47%
ORACLE INVESTMENT MANAGEMENT INC 1,638,395$13,680,5984.20%
Decheng Capital Management III (Cayman), LLC 1,463,872$12,223,3314.08%
VK Services, LLC 2,632,784$21,983,7462.93%
Iron Triangle Partners LP 1,800,000$15,030,0002.20%
BOURNE LENT ASSET MANAGEMENT INC 574,350$4,795,8222.11%
Deep Track Capital, LP 6,000,000$50,100,0001.93%
Jackson Square Partners, LLC 6,933,865$57,897,7731.93%
ARK Investment Management 29,822,440$249,017,3701.90%
Nikko Asset Management Americas, Inc. 13,447,666$112,153,5341.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders